#United States #Boston #Sartorius #Biomanufacturing #PI Forum

The Sartorius PI Forum: A Catalyst for Change in Biomanufacturing

Sartorius, a recognized leader in life sciences and biopharmaceuticals, has officially unveiled the Sartorius PI Forum, a pioneering event dedicated to advancing the field of process intensification (PI) for protein therapeutics. Hosted from June 24 to 26, 2025, at the luxurious Royal Sonesta Boston, this forum convenes industry trailblazers, researchers, and decision-makers to explore the futuristic landscape of drug manufacturing.

Revolutionizing Biomanufacturing

The focus of the forum is primarily on 'process intensification,' which is rapidly becoming the backbone of efficient drug development and production. The event features a comprehensive program that highlights significant breakthroughs in flexible manufacturing, automation, and sustainability—all essential for improving the speed and scalability of biopharmaceutical production. Participants will engage in high-level discussions with leading experts, gather insights from data-driven presentations, and participate in practical workshops designed to foster the application of PI technologies.

Maurice Phelan, President of Sartorius North America, emphasized the urgency of this topic by stating, "The pace of change in biomanufacturing is accelerating, and process intensification is at the heart of that transformation." By bridging the gap between discussion and action, this event promises to convert innovative ideas into real-world implementations.

Key Features of the Forum

The Sartorius PI Forum isn't just another industry conference; it's a hands-on experience showcasing the latest technologies and strategies critical to the future of biomanufacturing. Participants can look forward to:

• - Expert Presentations: Thought leaders will deliver talks on trending topics and innovative approaches in biomanufacturing.
• - Workshops: Intimate sessions aimed at applying PI technologies directly to current drug development processes.
• - Live Demonstrations: an opportunity to see the latest Sartorius solutions in action that could reshape future practices in the pharmaceutical industry.

Miriam Monge, Head of Customer Industry Advocacy Strategy BPS at Sartorius, added, "Forums like this are essential because they align strategy with solutions, contributing to the technologies that will define the next generation of therapies."

Sustainability and Future Trends

In today's world, sustainability in drug manufacturing is not just a goal but a necessity. The Sartorius PI Forum aims to shed light on sustainable practices that not only enhance manufacturing efficiency but also align with global environmental standards. With the industry's shift toward digital and sustainable solutions, the forum will cover pivotal trends that participants can leverage.

The insights shared at this event are invaluable for anyone involved in biopharmaceuticals, whether you are part of research and development, manufacturing, or regulatory affairs.

About Sartorius

Based in Göttingen, Germany, Sartorius has established itself as an international partner in the life sciences research and biopharmaceutical sectors. The company operates across 60 sites worldwide, offering a broad product lineup dedicated to bioprocessing solutions and lab products. With 2024 revenues around 3.4 billion euros and over 13,500 employees globally, Sartorius continues to expand its portfolio through strategic acquisitions and innovative technologies, solidifying its position as a leader in the industry.

For anyone aiming to stay ahead in biomanufacturing, the Sartorius PI Forum represents an unparalleled opportunity to engage with experts, gain fresh insights, and explore the next steps in this dynamic field. To learn more about this transformative event, visit Sartorius' official website and follow their updates on LinkedIn.